181 related articles for article (PubMed ID: 31596927)
1. Elevated Endogenous SDHA Drives Pathological Metabolism in Highly Metastatic Uveal Melanoma.
Chattopadhyay C; Oba J; Roszik J; Marszalek JR; Chen K; Qi Y; Eterovic K; Robertson AG; Burks JK; McCannel TA; Grimm EA; Woodman SE
Invest Ophthalmol Vis Sci; 2019 Oct; 60(13):4187-4195. PubMed ID: 31596927
[TBL] [Abstract][Full Text] [Related]
2. BAP1 mutant uveal melanoma is stratified by metabolic phenotypes with distinct vulnerability to metabolic inhibitors.
Han A; Purwin TJ; Bechtel N; Liao C; Chua V; Seifert E; Sato T; Schug ZT; Speicher DW; Harbour JW; Aplin AE
Oncogene; 2021 Jan; 40(3):618-632. PubMed ID: 33208912
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic Gq/11 signaling acutely drives and chronically sustains metabolic reprogramming in uveal melanoma.
Onken MD; Noda SE; Kaltenbronn KM; Frankfater C; Makepeace CM; Fettig N; Piggott KD; Custer PL; Ippolito JE; Blumer KJ
J Biol Chem; 2022 Jan; 298(1):101495. PubMed ID: 34919964
[TBL] [Abstract][Full Text] [Related]
4. Contribution of the STAT Family of Transcription Factors to the Expression of the Serotonin 2B (HTR2B) Receptor in Human Uveal Melanoma.
Benhassine M; Le-Bel G; Guérin SL
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163491
[TBL] [Abstract][Full Text] [Related]
5. Prognostication of uveal melanoma is simple and highly predictive using The Cancer Genome Atlas (TCGA) classification: A review.
Shields CL; Dalvin LA; Vichitvejpaisal P; Mazloumi M; Ganguly A; Shields JA
Indian J Ophthalmol; 2019 Dec; 67(12):1959-1963. PubMed ID: 31755428
[TBL] [Abstract][Full Text] [Related]
6. Lower Levels of Adiponectin and Its Receptor Adipor1 in the Uveal Melanomas With Monosomy-3.
Tura A; Thieme C; Brosig A; Merz H; Ranjbar M; Vardanyan S; Zuo H; Maassen T; Kakkassery V; Grisanti S
Invest Ophthalmol Vis Sci; 2020 May; 61(5):12. PubMed ID: 32396633
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of chromosome 3 alterations determined by microsatellite analysis in uveal melanoma: a long-term follow-up study.
Thomas S; Pütter C; Weber S; Bornfeld N; Lohmann DR; Zeschnigk M
Br J Cancer; 2012 Mar; 106(6):1171-6. PubMed ID: 22353812
[TBL] [Abstract][Full Text] [Related]
8. EFS shows biallelic methylation in uveal melanoma with poor prognosis as well as tissue-specific methylation.
Neumann LC; Weinhäusel A; Thomas S; Horsthemke B; Lohmann DR; Zeschnigk M
BMC Cancer; 2011 Aug; 11():380. PubMed ID: 21871071
[TBL] [Abstract][Full Text] [Related]
9. CD166high Uveal Melanoma Cells Represent a Subpopulation With Enhanced Migratory Capacity.
Djirackor L; Kalirai H; Coupland SE; Petrovski G
Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2696-2704. PubMed ID: 31242292
[TBL] [Abstract][Full Text] [Related]
10. Aggressive uveal melanoma displays a high degree of centrosome amplification, opening the door to therapeutic intervention.
Sabat-Pośpiech D; Fabian-Kolpanowicz K; Kalirai H; Kipling N; Coupland SE; Coulson JM; Fielding AB
J Pathol Clin Res; 2022 Jul; 8(4):383-394. PubMed ID: 35474453
[TBL] [Abstract][Full Text] [Related]
11. High EIF4E2 expression is an independent prognostic risk factor for poor overall survival and recurrence-free survival in uveal melanoma.
Yang B; Gu A; Wu Y
Exp Eye Res; 2021 May; 206():108558. PubMed ID: 33785306
[TBL] [Abstract][Full Text] [Related]
12. Development of new therapeutic options for the treatment of uveal melanoma.
Wang JZ; Lin V; Toumi E; Wang K; Zhu H; Conway RM; Madigan MC; Murray M; Cherepanoff S; Zhou F; Shu W
FEBS J; 2021 Nov; 288(21):6226-6249. PubMed ID: 33838075
[TBL] [Abstract][Full Text] [Related]
13. Integrated differential DNA methylation and gene expression of formalin-fixed paraffin-embedded uveal melanoma specimens identifies genes associated with early metastasis and poor prognosis.
Ness C; Katta K; Garred Ø; Kumar T; Olstad OK; Petrovski G; Moe MC; Noer A
Exp Eye Res; 2021 Feb; 203():108426. PubMed ID: 33387485
[TBL] [Abstract][Full Text] [Related]
14. Monosomy 3 Is Linked to Resistance to MEK Inhibitors in Uveal Melanoma.
Mergener S; Siveke JT; Peña-Llopis S
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201614
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Adaptations to MEK and CDK4/6 Cotargeting in Uveal Melanoma.
Teh JLF; Purwin TJ; Han A; Chua V; Patel P; Baqai U; Liao C; Bechtel N; Sato T; Davies MA; Aguirre-Ghiso J; Aplin AE
Mol Cancer Ther; 2020 Aug; 19(8):1719-1726. PubMed ID: 32430489
[TBL] [Abstract][Full Text] [Related]
16. Expression of the serotonin receptor 2B in uveal melanoma and effects of an antagonist on cell lines.
Weidmann C; Bérubé J; Piquet L; de la Fouchardière A; Landreville S
Clin Exp Metastasis; 2018 Mar; 35(3):123-134. PubMed ID: 29696577
[TBL] [Abstract][Full Text] [Related]
17. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
Liu J; Lu J; Li W
Front Immunol; 2021; 12():738068. PubMed ID: 34630418
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the proteasome activity and the turnover of the serotonin receptor 2B (HTR2B) in human uveal melanoma.
Le-Bel G; Benhassine M; Landreville S; Guérin SL
Exp Eye Res; 2019 Jul; 184():72-77. PubMed ID: 31002821
[TBL] [Abstract][Full Text] [Related]
19. Clinico-Pathological Association of Delineated miRNAs in Uveal Melanoma with Monosomy 3/Disomy 3 Chromosomal Aberrations.
Venkatesan N; Kanwar J; Deepa PR; Khetan V; Crowley TM; Raguraman R; Sugneswari G; Rishi P; Natarajan V; Biswas J; Krishnakumar S
PLoS One; 2016; 11(1):e0146128. PubMed ID: 26812476
[TBL] [Abstract][Full Text] [Related]
20. Depsipeptide inhibits migration of primary and metastatic uveal melanoma cell lines in vitro: a potential strategy for uveal melanoma.
Klisovic DD; Klisovic MI; Effron D; Liu S; Marcucci G; Katz SE
Melanoma Res; 2005 Jun; 15(3):147-53. PubMed ID: 15917695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]